Volitionrx limited appoints two new directors

Austin, texas, march 29, 2021 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, announced today the appointment of ms. kim nguyen and mr.

VNRX Ratings Summary

VNRX Quant Ranking